Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle DiseaseNews DeskJune 11, 20260 A Novartis RNA therapy reduced blood levels of a protein that’s a biological indicator of a particular form of muscular…
Healthcare Moves: A Monthly Summary of Hires, Exits and LayoffsNews DeskMay 29, 20260 This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended…